Open AccessDisabled‐1 is down‐regulated in clinical breast cancer and regulates cell apoptosis through NF ‐κB/Bcl‐2/caspase‐9
Author(s) -
Cao RangJuan,
Li Kai,
Xing WanYing,
Du Shuang,
Li Qiang,
Zhu XiaoJuan,
Cui ShuSen
Publication year - 2019
Publication title -
journal of cellular and molecular medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.44
H-Index - 130
eISSN - 1582-4934
pISSN - 1582-1838
DOI - 10.1111/jcmm.14047
Subject(s) - breast cancer , dab1 , cancer research , apoptosis , cancer , metastasis , caspase 3 , medicine , biology , pathology , programmed cell death , reelin , receptor , genetics
Disabled‐1 (Dab1) is best known as an adaptor protein regulating neuron migration and lamination during development. However, the exact function of Dab1 in breast cancer is unknown. In this study, we examined the expression of Dab1 in 38 breast cancer paraffin sections, as well as 60 paired frozen breast cancer and their adjacent tissues. Our results showed that Dab1 was reduced in breast cancer, and its compromised expression correlated with triple negative breast cancer phenotype, poor differentiation, as well as lymph node metastasis. Functional analysis in breast cancer cell lines demonstrated that Dab1 promoted cell apoptosis, which, at least partially, depended on its regulation of NF ‐κB/Bcl‐2/caspase‐9 pathway. Our study strongly suggests that Dab1 may be a potential tumour suppressor gene in breast cancer.